RLFTY
Price:
$1.41
Market Cap:
$36.28M
MindMaze Therapeutics Holding SA engages in the development of AI-powered neurotherapeutics and pharmacological treatments for brain disorders. It focuses on addressing neurological and neuropsychiatric conditions through advanced research, clinical development, and technology-driven solutions. The company is headquartered in Geneva, Switzerland.
Industry
Specialty Business Services
IPO Date
2021-11-23
Stock Exchange
OTC
Ticker
RLFTY
According to MindMaze Therapeutics Holding S.A. Sponsored ADR’s latest financial reports and current stock price. The company's current PE Ratio is -0.83. This represents a change of -6.01% compared to the average of -0.88 of the last 4 quarters.
The mean historical PE Ratio of MindMaze Therapeutics Holding S.A. Sponsored ADR over the last ten years is -13.41. The current -0.83 PE Ratio has changed 518.74% with respect to the historical average. Over the past ten years (40 quarters), RLFTY's PE Ratio was at its highest in in the June 2020 quarter at 2.34. The PE Ratio was at its lowest in in the December 2006 quarter at -817648.66.
Average
-13.41
Median
-3.14
Minimum
-82.93
Maximum
-0.24
Discovering the peaks and valleys of MindMaze Therapeutics Holding S.A. Sponsored ADR PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 29.30%
Maximum Annual PE Ratio = -0.24
Minimum Annual Increase = -98.93%
Minimum Annual PE Ratio = -82.93
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | -3.08 | 1.19% |
| 2023 | -0.24 | -90.46% |
| 2022 | -2.50 | -61.22% |
| 2021 | -6.44 | -92.23% |
| 2020 | -82.93 | 29.30% |
| 2019 | -0.28 | -98.93% |
| 2018 | -26.33 | 282.37% |
| 2017 | -6.89 | 205.31% |
| 2016 | -2.26 | -29.58% |
| 2015 | -3.20 | 19.41% |
The current PE Ratio of MindMaze Therapeutics Holding S.A. Sponsored ADR (RLFTY) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-1.94
5-year avg
-19.04
10-year avg
-13.41
MindMaze Therapeutics Holding S.A. Sponsored ADR’s PE Ratio is greater than Helix BioPharma Corp. (-31.11), greater than Calliditas Therapeutics AB (publ) (-23.95), less than PsyBio Therapeutics Corp. (-0.00), greater than ZIVO Bioscience, Inc. (-4.72), greater than Amplia Therapeutics Limited (-6.99), greater than Arch Biopartners Inc. (-28.53), greater than Oncotelic Therapeutics, Inc. (-19.31), greater than Vext Science, Inc. (-3.16), greater than Sernova Corp. (-3.28), greater than Vicapsys Life Sciences, Inc. (-81.12),
| Company | PE Ratio | Market cap |
|---|---|---|
| -31.11 | $132.13M | |
| -23.95 | $15.89M | |
| -0.00 | $1.27K | |
| -4.72 | $40.83M | |
| -6.99 | $51.31M | |
| -28.53 | $51.20M | |
| -19.31 | $33.46M | |
| -3.16 | $52.47M | |
| -3.28 | $38.89M | |
| -81.12 | $48.56M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like MindMaze Therapeutics Holding S.A. Sponsored ADR using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like MindMaze Therapeutics Holding S.A. Sponsored ADR or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is MindMaze Therapeutics Holding S.A. Sponsored ADR's PE Ratio?
How is the PE Ratio calculated for MindMaze Therapeutics Holding S.A. Sponsored ADR (RLFTY)?
What is the highest PE Ratio for MindMaze Therapeutics Holding S.A. Sponsored ADR (RLFTY)?
What is the 3-year average PE Ratio for MindMaze Therapeutics Holding S.A. Sponsored ADR (RLFTY)?
What is the 5-year average PE Ratio for MindMaze Therapeutics Holding S.A. Sponsored ADR (RLFTY)?
How does the current PE Ratio for MindMaze Therapeutics Holding S.A. Sponsored ADR (RLFTY) compare to its historical average?